Status:
NOT_YET_RECRUITING
The Application Value of Spectral CT in the Accurate Staging of Breast Cancer
Lead Sponsor:
Yunnan Cancer Hospital
Conditions:
Breast Adenocarcinoma
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Spectral CT was used to prospectively collect medical images and clinical data related to breast cancer, evaluate the effect of image quality in the diagnosis of breast cancer, and evaluate the applic...
Eligibility Criteria
Inclusion
- (a) Chest quark energy spectrum CT examination was performed within 1 week before treatment
- (b) Age ≥ 18
- (c) Suspected breast cancer patients
- (d) Patients who signed informed consent
Exclusion
- (a) Severe cardiac, pulmonary and renal insufficiency
- (b) Allergic to iodine contrast media
- (c) Unable to cooperate to complete CT examination
- (d) Quark spectrum CT image is poor and cannot be used
- (e) Male, pregnant and lactating female
- (f) Combined with other tumor history
- (g) Incomplete clinical and pathological data
- (h) Pathologically confirmed non breast cancer
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06977412
Start Date
June 1 2025
End Date
May 31 2026
Last Update
May 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.